🔎 Trials Near Me

홈 › 전립선암 › 텍사스

텍사스의 전립선암 임상 시험

전립선암 관련 연구 115개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.

텍사스의 도시

공식 연구 텍스트(영어)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • New Experimental Therapeutics - NEXT Oncology, Austin
  • Texas Oncology, Bedford
  • UT Southwest Simmons Cancer Center, Dallas
  • 외 2개
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04585750

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
  • 외 1개
피험자 모집 중3상
18세 이상 · 남성 · 2026. 10. 2. 업데이트됨 · NCT06931340

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

  • Covenant Medical Center-Lakeside, Lubbock
피험자 모집 중3상
18세 이상 · 남성 · 2026. 10. 2. 업데이트됨 · NCT07200830

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • University of Texas MD Anderson Cancer Center, Houston
  • South Texas Accelerated Research Therapeutics (START), San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06465069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • The Don and Sybil Harrington Cancer Center, Amarillo
  • UT MD Anderson Cancer Center, Houston
  • Audie L Murphy VA Hospital, San Antonio
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • Parkland Memorial Hospital, Dallas
  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • 외 2개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06632977

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06172478

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
  • 외 1개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT03866382

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

  • Urology Austin, Austin
피험자 모집 중4상
18세 이상 · 남성 · 2026. 9. 29. 업데이트됨 · NCT07569926

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

  • MD Anderson Cancer Center, Houston
  • South Texas Accelerated Research Therapeutics, LLC (START), San Antonio
피험자 모집 중1상
18세 이상 · 남성 · 2026. 9. 28. 업데이트됨 · NCT06095089

Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial

  • Urology Austin, Austin
피험자 모집 중
18세 이상 · 남성 · 2026. 9. 28. 업데이트됨 · NCT06496256

DESTINY-PANTUMOUR04

  • Research Site, Dallas
피험자 모집 중관찰 연구
18세 ~ 130세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07124000

Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study

  • The University of Texas M. D. Anderson Cancer Center, Houston
피험자 모집 중초기 1상
18세 이상 · 남성 · 2026. 9. 25. 업데이트됨 · NCT06759701

Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer

  • M D Anderson Cancer Center, Houston
피험자 모집 중
18세 이상 · 남성 · 2026. 9. 25. 업데이트됨 · NCT07377006

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

  • Research Site, Houston
피험자 모집 중1/2상
18세 ~ 130세 · 남성 · 2026. 9. 25. 업데이트됨 · NCT07181161

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

  • NEXT Oncology, Austin
  • MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 이상 · 남성 · 2026. 9. 25. 업데이트됨 · NCT06800313

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  • Texas Oncology - Central/South Texas ( Site 8003), Austin
  • Texas Oncology - DFW ( Site 8001), Dallas
  • Texas Oncology - Gulf Coast ( Site 8002), Houston
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06136650

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  • University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
  • University of Texas Southwestern Medical Center - William P. Clements, Jr., University Hospital, Dallas
  • University of Texas Southwestern Simmons Cancer Center - Redbird, Dallas
  • 외 5개
피험자 모집 중3상
18세 이상 · 남성 · 2026. 9. 24. 업데이트됨 · NCT07028853

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

  • START Dallas-Fort Worth, Fort Worth
  • NEXT Houston, Houston
  • NEXT Oncology, San Antonio
피험자 모집 중1상
18세 이상 · 남성 · 2026. 9. 24. 업데이트됨 · NCT07719361

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

  • Texas Oncology, Dallas
  • Urology San Antonio, San Antonio
피험자 모집 중2/3상
18세 ~ 100세 · 남성 · 2026. 9. 22. 업데이트됨 · NCT06780670

A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer

  • Mary Crowley Cancer Research, Dallas
피험자 모집 중1상
18세 이상 · 남성 · 2026. 9. 22. 업데이트됨 · NCT07570979

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • Texas Oncology - DFW (Sammons CC), Dallas
  • MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07114601

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  • The Center for Cancer and Blood Disorders, Arlington
  • University of Texas Southwestern Medical Center, Dallas
  • Renovatio Clinical, Houston
  • 외 2개
피험자 모집 중3상
18세 이상 · 남성 · 2026. 9. 22. 업데이트됨 · NCT07213674

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  • Urology Austin, Lakeway
  • Urology San Antonio, San Antonio
  • Woodlands Cancer Institute American Oncology Partners, The Woodlands
피험자 모집 중3상
18세 ~ 100세 · 남성 · 2026. 9. 22. 업데이트됨 · NCT06855277

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

  • Research Site, Austin
  • Research Site, Austin
  • Research Site, Houston
  • 외 2개
피험자 모집 중3상
18세 이상 · 남성 · 2026. 9. 18. 업데이트됨 · NCT06952803

Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)

  • MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 이상 · 남성 · 2026. 9. 18. 업데이트됨 · NCT06085729

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston
피험자 모집 중2상
18세 이상 · 남성 · 2026. 9. 17. 업데이트됨 · NCT05011383

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • Parkland Health & Hospital System ( Site 0069), Dallas
  • UT Southwestern Medical Center ( Site 0039), Dallas
  • University of Texas-MD Anderson Cancer Center ( Site 0055), Houston
피험자 모집 중3상
18세 이상 · 남성 · 2026. 9. 17. 업데이트됨 · NCT06925737

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

  • University of Texas MD Anderson Cancer Center, Houston
  • Next Oncology - Dallas, Irving
피험자 모집 중1상
18세 이상 · 남성 · 2026. 9. 15. 업데이트됨 · NCT07493512

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

  • Urology Partners of North Texas (UPNT), Arlington
피험자 모집 중
18세 이상 · 남성 · 2026. 9. 14. 업데이트됨 · NCT06511141

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

  • Urology Austin, PLLC - Research Department, Austin
  • Urology Clinics of North Texas, Dallas
  • University of Texas Southwestern Medical Center, Dallas
  • 외 1개
피험자 모집 중3상
18세 이상 · 남성 · 2026. 9. 11. 업데이트됨 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • MD Anderson in The Woodlands, Conroe
  • Brooke Army Medical Center, Fort Sam Houston
  • UT MD Anderson Cancer Center, Houston
  • 외 3개
피험자 모집 중3상
18세 이상 · 남성 · 2026. 9. 10. 업데이트됨 · NCT05946213

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

  • Investigational Site Number: 401, Houston
피험자 모집 중1상
18세 이상 · 남성 · 2026. 9. 10. 업데이트됨 · NCT05997615

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

  • UT MD Anderson, Houston
  • NEXT Oncology, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06440005

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

  • SCRI Oncology Partners, Nashville
피험자 모집 중1상
18세 이상 · 남성 · 2026. 9. 8. 업데이트됨 · NCT05800665

Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

  • SCRI at Mary Crowley, Dallas
피험자 모집 중1상
18세 이상 · 남성 · 2026. 9. 3. 업데이트됨 · NCT07545811

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

  • Urology Clinics Of North Texas, Dallas
  • Urology Partners of North Texas (UPNT), Fort Worth
  • Houston Metro Urology (HMU), Houston
피험자 모집 중3상
18세 이상 · 남성 · 2026. 9. 3. 업데이트됨 · NCT07723248

Prostate Active Surveillance Study

  • University of Texas Health Science Center, San Antonio, San Antonio
피험자 모집 중관찰 연구
21세 이상 · 남성 · 2026. 9. 2. 업데이트됨 · NCT00756665

A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

  • University of Texas Southwestern Medical Center, Dallas
피험자 모집 중2상
18세 이상 · 남성 · 2026. 8. 31. 업데이트됨 · NCT05726292

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • START San Antonio, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 27. 업데이트됨 · NCT06582017

ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.